Inhibitex to Host Conference Call to Report Second Quarter 2009 Financial Results on August 11, 2009
July 27 2009 - 4:45PM
Business Wire
Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host
a conference call on Tuesday, August 11, 2009 at 9:00 a.m. EDT to
review the Company’s second quarter ended June 30, 2009 financial
results and provide an update on recent corporate developments. The
Company will issue a press release regarding its financial results
on the same day, prior to the conference call.
Webcast Information
To access the conference call, please dial (877) 407-8031
(domestic) or (201) 689-8031 (international). A replay of the call
will be available from 11:00 a.m. EDT on August 11 until September
11, 2009 at midnight. To access the replay, please dial (877)
660-6853 (domestic) or (201) 612-7415 (international) and reference
the account # 286 and the conference id # 329257. A live audio
webcast of the call and the archived webcast will be available in
the News and Events section of the Inhibitex website at
http://www.inhibitex.com.
About Inhibitex
Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a
biopharmaceutical company focused on developing products to treat
serious infectious diseases. The Company’s pipeline includes
FV-100, its clinical-stage oral nucleoside analogue in development
for the treatment of herpes zoster (shingles), as well as a series
of HCV nucleoside polymerase inhibitors and HIV integrase
inhibitors. Inhibitex has also licensed the use of its proprietary
MSCRAMM® protein technology to Wyeth for the development of
staphylococcal vaccines.
For additional information about the Company, please visit
www.inhibitex.com.
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jul 2023 to Jul 2024